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Purpose: Shared breast cancer treatment decision-making between patients and physicians increases
patient treatment satisfaction and compliance and is influenced by physician-related factors. Attitudes
and behaviors about patient involvement in breast cancer treatment decisions and treatment-related
communication were assessed by specialty among breast cancer physicians of women enrolled in the
Breast Cancer Quality of Care Study (BQUAL).
Results: Of 275 BQUAL physicians identified, 50.0% responded to the survey. Most physicians spend
46e60 min with the patient during the initial consult visit and 51.5% report that the treatment
decision is made in one visit. Oncologists spend more time with new breast cancer patients during
the initial consult (p ¼ 0.021), and find it more difficult to handle their own feelings than breast
surgeons (p ¼ <0.001).
Conclusion: Breast surgeons and oncologists share similar attitudes and behaviors related to patient
involvement in treatment decision-making, yet oncologists report more difficulty managing their own
feelings during the decision-making process.
 2012 Elsevier Ltd. All rights reserved.Introduction
Significant improvements in survival of breast cancer that have
been achieved in the past several decades have been attributed to
early detection and the widespread use of adjuvant therapy.1 The
use of biomarkers for the human epidermal growth factor receptor
2 (HER2), quantification of estrogen/progesterone receptors, and
identification of genetic markers as prognostic and predictive tools
enable clinicians to customize treatment to maximize benefits and
improve outcomes for patients.2,3 In cases where more than one
treatment option is acceptable,4 the patient’s involvement in the
treatment decision and her preference for one treatment over
another and/or avoidance of side effects over another is crucial.: þ1 212 342 6802.
).
All rights reserved.
GC, et al., A survey of breast
://dx.doi.org/10.1016/j.breastEvidence suggests that women who are engaged in the treatment
decision-making process to the extent with which they are most
comfortable are more likely to comply with treatment, report
increased satisfaction with the treatment and experience better
quality of life.5e7
Over the course of breast cancer care, a woman typically
engages in discussions for primary treatment with a breast surgeon
and, quite often, with oncologists (medical and radiation) for
adjuvant treatment. In her encounters with each physician along
the breast cancer care continuum, a vast amount of specialized
information is communicated, along with a spectrum of treatment
options and alternatives e all requiring consideration and a deci-
sion to be made.
We examined attitudes and behaviors related to patient
involvement in treatment decision-making and patientephysician
communication attitudes among oncologists and breast surgeons,cancer physicians regarding patient involvement in breast cancer
.2012.10.001
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potential to influence the treatment decision process and, thus the
receipt of optimal breast cancer care may provide opportunities for

















wasverifiedby the research investigatorateach recruitment siteand
emailaddresseswereobtained.
Physicians were sent a study invitation via email and a secure,
personalized link to the SurveyMonkey website between July
2009 and July 2010. A cover letter informed the physician how he/
she was selected for this study without revealing the identity of the
BQUAL study patient who had supplied their name. An incentive
($50 gift card) for the completion and return of the survey was
offered. In the event of a non-viable email address, surveys were
sent via U.S. Postal Mail Service in the same manner as the elec-
tronic surveys. All procedures and a waiver of written informed
consent were approved by the Institutional Review Board of each
recruitment site, the U.S. Army Medical Research and Materiel
Command Office of Research Protection and Human Research
Protection Office.
The survey was comprised of two sections: the first gathered
information related to physician demographics, practice charac-
teristics, and patient population characteristics, and the second
assessed physician attitudes and behaviors related to breast cancer
treatment decisions and treatment-related patientephysician
communication barriers. Demographics included physician
specialty (oncologist vs. breast surgeon), gender, age, race (White,
Asian, other race), nativity (U.S. born vs. non-U.S.), years of expe-
rience, recruitment site of BQUAL participant (New York, Northern
California, or metropolitan Detroit), country where attended
medical school (U.S. vs. non-U.S.), and specialty board certification.
Practice characteristics consisted of practice type (private vs. other),
and teaching hospital, NCI-designated cancer center affiliation,
percent of patients being evaluated, treated or followed for breast
cancer, new breast cancer patients in the past 6 months, and new
patients per week. For patient population characteristics, race/
ethnicity (White, black/African American, Hispanic, Asian, and
other race), insurance coverage (Medicare, private insurance,
Medicaid, none or other), and primary patient population language
other than English (Spanish vs. other) was assessed.
Factors surrounding the treatment decision-making process
that were examined were length of the initial consult visit in
minutes, number of visits needed in order tomake a treatment plan
decision, and the percent of patients enrolled into clinical trials. To
evaluate attitudes toward patient involvement in the treatment
decision-making process, a measure developed by Liberati et al.9
was used in which respondents were asked to indicate on
a 5-point Likert scale the extent to which they agreed or disagreedPlease cite this article in press as: Hillyer GC, et al., A survey of breas
treatment decisions, The Breast (2012), http://dx.doi.org/10.1016/j.breastwith a series of 10 statements, such as “encouraging patient to
participate [in treatment decisions] may do more harm than good”
or “patients who participate in treatment decisions make a better
adjustment to the disease”. Five negatively worded statements
were reverse coded; thus, higher scores indicated more favorable
attitudes toward patient involvement in treatment decisions
whereas lower scores indicated less favorable attitudes.
The measure of treatment communication behaviors was
adapted from Braddock et al.10 Respondents were queried about 10
separate communication components that would provide patients
with information sufficient to make an informed treatment deci-
sion. Examples include discussing the patient’s role in the decision-
making process, explaining the potential risks and benefits of
treatment and alternatives to treatment, and asking the patient her
opinion about her treatment options. Responses were coded as “yes
or no”. To examine barriers surrounding the communication of
treatment information to patients, respondents were asked about
perceived difficulty in dealing with the patient’s family, responding
to the patient’s needs, being honest without depressing the patient,
handling personal negative feelings, not disclosing poor prognosis
at the request of the family, and giving specific probabilities of the
treatment not working based on the work of Baile et al.11 Responses
ranged from “not difficult at all” to “very difficult” and were later
dichotomized as “difficult/not difficult”.
Descriptive analyses included frequency distributions for cate-
gorical variables and mean and standard deviation for continuous
variables. Using Chi-square analysis and Student’s t with a two-
sided a ¼ 0.05, we compared physician, practice and patient pop-
ulation characteristics and treatment-related attitudes and behav-
iors by physician specialty. Results were considered significant
using p  0.05. All analyses were conducted using IBM SPSS
Statistics version 19.
Results
Overall, 1157 women with newly diagnosed primary, invasive
breast cancer were enrolled to the BQUAL study for whom a total of
275 treating physicians were identified. Of these physicians, 137
were medical oncologists (49.8%) and 138 (50.2%) breast surgeons.
One hundred thirty eight physicians (47.8% oncologists, 52.2%
breast surgeons) responded to the survey, for a response rate of
50.0%, representing 80% (921/1157) of BQUAL study participants.
There was no statistically significant difference between physician
responders and non-responders by specialty or recruitment site.
Fig. 1 shows the distribution of treating physicians by site (New
York City, Northern California, and metropolitan Detroit) and
specialty (oncologist vs. breast surgeon) identified by the BQUAL
participants. Women recruited from Northern California more
often identified breast surgeons (57.0% vs. 43.0%) as their treating
physician compared to New York City and the metropolitan Detroit
area, where participants more often reported receiving their care
from oncologists (p ¼ 0.008) (Fig. 1).
Respondents were predominantly White (67.4%), U.S. born
(72.5%) males (63.0%) between the ages of 40 and 59 years (34.6%)
(Table 1). Most were engaged in private practice (65.4% vs. 34.6%
other practice type), and affiliated with a teaching hospital (69.9%).
Compared to oncologists in our sample, breast surgeons were more
likely to be U.S. born (80.6% vs. 63.6%, p ¼ 0.03) and to have
attended a non-U.S. medical school (94.4% vs. 75.4%, p ¼ 0.002).
Practice and patient population characteristics varied between
oncologists and surgeons in terms of the number of breast cancer
patients seen in the past 6 months, the number of new patients
seen on a weekly basis, and the insurance coverage of their
respective patient populations. Oncologists more often reported
evaluating, treating and following a larger proportion of theirt cancer physicians regarding patient involvement in breast cancer
.2012.10.001
Fig. 1. Comparison of total treating physicians (N ¼ 275) identified by participants enrolled in the Breast Cancer Quality of Care Study (BQUAL) May 2006 through July 2010 and
physicians respondents (N ¼ 138) by recruitment site and specialty (oncologist, N ¼ 66 vs. breast surgeon, N ¼ 72).
G.C. Hillyer et al. / The Breast xxx (2012) 1e7 3patient population (40.6% vs. 29.4%, p ¼ 0.015) and having a larger
proportion of their practice comprised of patients diagnosed in the
past 6 months with breast cancer (39.1% vs. 20.9%, p ¼ <0.001)
compared to surgeons. Conversely, surgeons reported a new
patient load more than twice that of oncologists (19.5% vs. 7.2%,
p ¼ <0.001). The majority of patients treated by our respondents
were White (51.9%) and privately insured (49.3%). Oncologists
reported that one-third of their patients were Medicare insured as
opposed to 18.9% for surgeons (p ¼ <0.001) whereas surgeons
reported significantly more patients with other types of insurance
(21.8% vs. 4.9%, p ¼ 0.002) than did oncologists.
Physicians’ behaviors and attitudes toward breast cancer treat-
ment decision-making are displayed in Table 2. More than one-
third (38.3%) of physicians spend 46e60 min with the patient
during the initial consult visit. Approximately half of the
respondents stated that a single visit is needed to come to
a treatment decision and 68.9% reported enrolling 10% of their
breast cancer patients into clinical trials. Overall, respondents
preferred a less patient-oriented approach toward treatment
decision-making (53.8% vs. 46.2% more patient-oriented) but
engaged in communication that explored the patient’s treatment
preference and asked for her opinion about treatment options
discussed (97.0%). Nearly all respondents reported providing clear
statements to their patients of the importance of the treatment
decision (96.2%), discussing alternatives to treatment and
explaining risks and benefits of treatment (97.7%). Fewer, though
a substantial number, encourage women to involve their family
members and significant others in the treatment decision (84.1%).
Comparing physicians’ attitudes and behaviors related to treatment
decisions by specialty showed that oncologists in our sample spend
more time with new breast cancer patients during the initial
consult (p ¼ 0.021), have more difficulty dealing with the patient’s
family (60.6% vs. 43.9%, p ¼ 0.055), tend to find it more difficult to
be honest with the patient without depressing her (59.1% vs. 42.4%,
p ¼ 0.055), and find it more difficult to handle their own feelings
with regard to patient treatment decisions (60.6% vs. 25.8%,
p ¼ <0.001) than do breast surgeons.
In separate analyses we explored the influence of select physi-
cian characteristics (gender and age), practice characteristics (type,
affiliation with an NCI cancer center or teaching hospital and site)
and patient population composition (race and insurance coverage)
on physician’s attitudes and behaviors. We found no significantPlease cite this article in press as: Hillyer GC, et al., A survey of breast
treatment decisions, The Breast (2012), http://dx.doi.org/10.1016/j.breastassociations between these factors and whether a physician
preferred a patient-oriented approach over a paternalistic one.
Further, we found that patient population characteristics did not
influence physician attitudes and behaviors toward treatment
decisions.
With regard to treatment communication behaviors, male
physicians more often reported not discussing the patient’s role in
treatment decision-making (15.7% vs. 4.1%, p ¼ 0.04). All older
physicians (50 years) reported discussing alternatives to each
treatment, including doing nothing at all, with their patients as
opposed to 93.2% of younger physicians (p ¼ 0.046) but less often
reported providing patients enough information to make decisions
on their own (17.5% vs. 5.5% younger, p ¼ 0.028). Physicians in
private practice (4.8% vs. 17.4% in other types, p ¼ 0.017), and
respondents from the metropolitan Detroit area (71.4% vs. New
York with 87.9% and California with 94.0%, p ¼ 0.03) less often
talked to their patients about the uncertainties associated with
each treatment. Affiliation with teaching hospital was associated
with encouraging the patient to involve her family and significant
others in the treatment decision more often compared to physi-
cians in community hospitals (89.1% vs. 74.4%, p ¼ 0.03). Affiliation
with an NCI cancer center, however, had no effect on physician
treatment decision-making attitudes.
When assessing barriers to treatment communication, we found
that physicians affiliated with an NCI cancer center had less diffi-
culty withholding a poor prognosis at the request of the family
compared to those with no such affiliation (9.8% vs. 1.2%, p ¼ 0.02).
Male physicians found it less difficult to not disclose a poor prog-
nosis if the patient did not ask (20.7% vs. 6.4%, p ¼ 0.03) and found
giving specific probabilities of the treatment not working less
difficult (36.1% vs. 19.1%, p ¼ 0.04) compared to female physicians.
Discussion
In this survey of attitudes and behaviors related to patient
involvement in treatment making decisions among a group of
physicians providing breast cancer care, we found few differences
by physician specialty. Oncologists tend to spend more time during
the initial consult and more often report struggling with their own
emotions than do surgeons. These, however, may be a reflection of
the relatively longer-term relationship a patient has with her
oncologist and differences in the decisions being made such ascancer physicians regarding patient involvement in breast cancer
.2012.10.001
Table 1
Physician, practice, and patient population characteristics of physicians (medical oncologists and breast surgeons) referring participants to the Breast Cancer Quality of Care
Study (BQUAL) (N ¼ 138), May 2006 through July 2010.
Total N ¼ 138 Oncologist N ¼ 66 Surgeon N ¼ 72 p Value
N % N % N %
Physician characteristics
Gender 0.40
Male 87 63.0 44 66.7 43 59.7
Female 51 37.0 22 33.3 29 40.3
Age 0.95
30e39 31 22.8 16 24.6 15 21.1
40e49 47 34.6 22 33.8 25 35.2
50e59 40 29.4 18 27.7 22 31.0
60e69 18 13.2 9 13.8 9 12.7
Race/ethnicity 0.09
White 93 67.4 39 59.1 54 75.0
Asian 40 29.0 25 37.9 15 20.8
Other 5 3.6 2 3.0 3 4.2
Nativity 0.03
U.S. born 100 72.5 42 63.6 58 80.6
Non-U.S. born 38 27.5 24 36.4 14 19.4
Years of experience 0.14
0e10 16 11.9 11 16.9 5 7.2
11e20 48 35.8 18 27.7 30 43.5
21e30 39 29.1 19 29.2 20 29.0
31þ 31 23.1 17 26.2 14 20.3
Recruitment site 0.06
New York 33 23.9 21 31.8 12 16.7
Michigan 14 10.1 8 12.1 6 8.3
California 91 65.9 37 56.1 54 75.0
Medical school country 0.002
U.S. medical school 117 85.4 49 75.4 68 94.4
Non-U.S. medical school 20 14.6 16 24.6 4 5.6
Board certificationa e
Medicine 55 39.9 55 83.3 e e
Surgery 71 51.4 e e 71 98.6
Medical oncology 57 41.3 57 100.0 e e
Surgical oncology 3 2.2 e e 3 4.2
Other 20 14.5 18 27.3 2 2.8
Practice characteristics
Practice type 0.10
Private 89 65.4 38 58.5 51 71.8
Other 47 34.6 27 41.5 20 28.2
Teaching hospital affiliation 0.43
Yes 95 69.9 44 66.7 51 72.9
No 41 30.1 22 33.3 19 27.1
NCI-designated cancer center affiliation 0.42
Yes 43 32.1 19 28.8 24 35.3
No 91 67.9 47 71.2 44 64.7
Total N ¼ 138 Oncologist N ¼ 66 Surgeon N ¼ 72 p Value
M SD M SD M SD
% Patients evaluating, treating
and following for breast cancer
37.9 25.5 40.6 26.7 29.4 26.2 0.015
% New patients in last 6 months
with breast cancer
30.0 26.5 39.1 27.4 20.9 21.7 <0.001
% New patients per week 13.5 10.8 7.2 3.6 19.5 11.9 <0.001
Patient population characteristics
Race/ethnicity (%)
White 51.9 21.4 53.7 22.1 49.4 21.2 0.27
Black 17.6 14.8 19.1 16.4 16.2 13.5 0.30
Hispanic 17.3 14.6 17.2 17.1 18.3 12.6 0.68
Asian 9.8 11.5 7.5 8.9 11.7 13.3 0.04
Other 2.1 4.2 2.3 4.7 2.1 3.7 0.84
Insurance coverage (%)
Medicare 25.7 18.8 33.9 18.0 18.9 16.8 <0.001
Private insurance 49.3 34.8 48.8 29.5 49.6 38.8 0.90
Medicaid 8.7 17.7 10.8 20.8 7.0 14.7 0.25
No insurance 2.3 5.9 3.0 7.6 1.5 3.3 0.16
Other 13.6 30.5 4.9 15.5 21.8 37.8 0.002
Language other than English spoken (%)
Spanish 12.6 14.6 12.6 17.4 13.2 12.5 0.82
Other 10.0 11.9 7.9 7.9 10.1 11.0 0.23
a More than one response possible; total >100%.
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Table 2
Physicians’ breast cancer treatment decision related behaviors and attitudes.
Total N ¼ 138 Oncologist N ¼ 66 Surgeon N ¼ 72 p Value
N % N % N %
Treatment decision making
Initial consult visit, minutes 0.021
0e35 33 24.8 9 13.6 24 35.8
36e45 41 30.8 21 31.8 20 29.9
46e60 51 38.3 31 47.0 20 29.9
>60 8 6.0 5 7.6 3 4.5
Visits to make treatment decision 0.16
1 68 51.5 30 45.5 38 57.6
>1 64 48.5 36 54.5 28 42.4
Percent enrolled in clinical trials 0.07
10 84 68.9 50 75.8 34 60.7
>10 38 31.1 16 24.2 22 39.3
Attitudes toward patient involvement in treatment decision-making
Patient-oriented 0.48
Yes 60 46.2 28 43.1 32 49.2
No 70 53.8 37 56.9 33 50.8
MD treatment communication behaviors
Discuss the patient’s role in the decision-making process 0.78
Yes 117 88.6 59 89.4 58 87.9
No 15 11.4 7 10.6 8 12.1
Provide a clear statement of what is at issue to clarify what is being decided 0.65
Yes 127 96.2 63 95.5 64 97.0
No 5 3.8 3 4.5 2 3.0
Discuss alternatives to each treatment including doing nothing at all 0.18
Yes 126 96.2 64 98.5 62 93.9
No 5 3.8 1 1.5 4 6.1
Explain the potential benefits and risks of treatment and alternatives to treatment 0.08
Yes 129 97.7 66 100.0 63 95.5
No 3 2.3 0 0.0 3 4.5
Talk about the uncertainties associated with each treatment 0.15
Yes 118 90.1 57 86.4 61 93.8
No 13 9.9 9 13.5 4 6.2
Assess the patient’s understanding of what has been said 0.54
Yes 120 90.9 61 92.4 59 89.4
No 12 9.1 5 7.6 7 10.6
Explore the patient’s preference and ask for her opinion about the treatment
options discussed
0.31
Yes 128 97.0 63 95.5 65 98.5
No 4 3.0 3 4.4 1 1.5
Encourage the woman to involve family members and significant others in
treatment decisions
0.23
Yes 111 84.1 53 80.3 58 87.9
No 21 15.9 13 19.7 8 12.1
Provide patients with enough information to make their own treatment decisions 0.57
Yes 118 89.4 58 87.9 60 90.9
No 14 10.6 8 12.1 6 9.1
Ask patients their opinion about their treatment options 0.40
Yes 126 95.5 64 97.0 62 93.9
No 6 4.5 2 3.0 4 6.1
Treatment plan communication barriers
Dealing with the patient’s family 0.055
Not difficult 63 47.7 26 39.4 37 56.1
Difficult 69 52.3 40 60.6 29 43.9
Responding to the patient’s emotions 0.09
Not difficult 49 37.4 20 30.3 29 44.6
Difficult 82 62.6 46 69.7 36 55.4
Being honest without depressing the patient 0.055
Not difficult 65 49.2 27 40.9 38 57.6
Difficult 67 50.8 39 59.1 28 42.4
Handling your own feelings <0.001
Not difficult 75 56.8 26 39.4 49 74.2
Difficult 57 43.2 40 60.6 17 25.8
Not disclosing poor prognosis at the request of the family 0.16
Not difficult 5 4.0 1 1.6 4 6.5
Difficult 121 96.0 63 98.4 58 93.5
Not disclosing poor prognosis if the patient doesn’t ask 0.55
Not difficult 20 15.5 9 13.6 11 17.5
Difficult 109 84.5 57 86.4 52 82.5
Giving specific probabilities of treatment not working 0.94
Not difficult 39 30.0 20 30.3 19 29.7
Difficult 91 70.0 46 69.7 45 70.3
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chemotherapy vs. the type of surgery to be done.
Although others have suggested that a physician’s motivation to
involve patients in the treatment making decision varies by
physician cancer site specialty and clinical discipline (oncology vs.
surgery),12 we found no evidence of such an association in our
cohort of breast cancer specialists. Motivation, rather, is complex,
quite variable and largely dependent upon the interplay between
characteristics of the disease, the patient, and the physician. When
a treatment may impact the patient’s lifestyle (fertility or sexual
function) or self-image (disfiguring surgery), or when disease
progresses and the goals of treatment need to be realigned,
physicians are more likely to invite the patient into the treatment
decision-making process.12 The decision to seek patient involve-
ment, however, is tempered by the physician’s appraisal of patient
characteristics, such as age, cultural background, personality style,
cognitive function and anxiety level12,13 as well as by the physi-
cian’s personal attitudes and beliefs surrounding the patient, the
treatment, and patient involvement in the treatment decision-
making process.
During the same office visit when a woman first learns of her
breast cancer diagnosis or disease progression, when she is likely
experiencing feelings of disbelief, fear, anxiety, and stress, she is
oftentimes expected to make a treatment decision. Physician
respondents indicated that most treatment decisions are made
during this visit, which is generally less than one hour in duration.
Nearly unanimously, the physicians in our study, both oncologists
and breast surgeons, reported exploring the patient’s treatment
decision-making preference and probing for her opinions about the
treatment options discussed during this crucial visit.
Theoretically, there are three approaches to treatment decision-
making: paternalistic, where the physician actively makes the
decision and the patient assumes a passive role; a consumer-
oriented model whereby the physician provides information and
the patient actively chooses a treatment plan; and an intermediate
approach in which the decision is shared between the patient and
her physician.14e16 Shared decision-making (SDM) is increasingly
the standard of care in cancer treatment.17 First described in 1982,
SDM is a conceptual framework that supports the discussion of
medical treatments and options and evaluates patient preferences
for involvement in the treatment decision. Knowledge and
concerns exchanged between patients and their physicians provide
the physician with an understanding of the patient’s values, ideas,
and outcome expectations that are used to inform the treatment
decision-making process.18
Current trends favor SDM and this is reflected in the number of
respondents in our study who reported that they provide enough
information for a woman to make her own decision, assess the
patient’s understanding of what has been discussed, and confer
with the patient on her preferred role in the decision-making
process e all key aspects of SDM. Between 43 and 89% of women
with a breast cancer diagnosis prefer to have an active or collabo-
rative role in their breast cancer care19e22 and this preference varies
by age and level of education.23,24
Incongruity between the physician’s perception of the patient’s
desired level of involvement in the treatment decision and that
actually preferred by the patient may have dramatic conse-
quences.19 Evidence suggests that approximately 40% of breast
cancer patients do not fulfill their preferred role in their treatment
decision4,25 and this failure for a patient to achieve her preferred
level of control in the treatment decision has been associated with
decisional conflict and delay in treatment initiation, decisional
regret, poorer quality of life, and decreased treatment satisfaction.26
That no significant differences in attitudes or behaviors toward
sharing the treatment making decision with their patients werePlease cite this article in press as: Hillyer GC, et al., A survey of breas
treatment decisions, The Breast (2012), http://dx.doi.org/10.1016/j.breastfound between surgeons and oncologists is not unexpected.
Evidence suggests that achieving the patient’s desired level of input
to the treatment decision is dependent upon the patientephysician
relationship and the quality of patientephysician communication27
and these factors transcend physician specialty. In a study of older
breast cancer patients and their surgeons, womenwere more likely
to perceive having a treatment choice and to be satisfied with their
treatment when there was a high degree of surgeon-initiated
communication.28 Similarly, oncologists’ verbal and non-verbal
behaviors influenced the patientephysician communication and
were predictive of greater patient involvement in adjuvant breast
cancer treatment decisions and lower patient decisional regret.29
The results of this study provide insight to the breast cancer
treatment decision-making process and the barriers to treatment
decisions among breast cancer specialists providing care to a large
cohort of breast cancer patients recruited from three sites across
the United States. Our study is limited in that we present self-
reported behaviors and attitudes that were neither directly
observed nor confirmed by patient report. It is possible that
physicians may have over-reported behaviors they believed to be
socially desirable. In actual practice, physician communication
behavior and attitudes are influenced by a host of complex factors
including the emotional, social, and personal context of the patient,
the complexity and urgency of the decision at hand, the patient’s
desire to participate in the decision, and the amount of information
needed by the patient to feel sufficiently informed to make
a treatment decision.
Conclusion
Our study demonstrates that specialists (breast surgeons and
oncologists) involved in the care of a large cohort of women with
breast cancer share similar attitudes and beliefs about patient
involvement in the treatment decision-making. Despite minor
demographic and patient population characteristic differences,
these physicians report communicating treatment information to
the patient in a manner consistent with shared decision-making,
known to enable patients to contribute to their treatment plan.
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